Moreover, serum level of FGF21 has been suggested as a potential biomarker of many metabolic syndromes, such as type 2 diabetes (T2D), nonalcoholic fatty liver, hyperlipidemia, and cardiovascular diseases [19,20]. This evidence concerns the gene FGF21 and cardiovascular disorder.